PIK3CA and head and neck squamous cell carcinoma: In this study we investigated the response to a pan PI3K inhibitor, BKM120, and a dual PI3K/mTOR inhibitor, GDC0980, in three HPV-positive and three HPV-negative HNSCC cell lines alone and in combination with RT.